BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures

  December 11, 2024

   · 

  6 min read
• Press Releases

  NCCN Announces Funding for a Prostate Cancer Research Project

  December 11, 2024

   · 

  3 min read
• Press Releases

  Mana.bio Presents Broad Improvements to Systemic Lipid Nanoparticle Tolerability by Leveraging a Novel AI-Driven Safety Model

  December 11, 2024

   · 

  3 min read
• Press Releases

  Expression Therapeutics Announces Promising Phase 1 Results for Groundbreaking Hemophilia A Gene Therapy at ASH

  December 11, 2024

   · 

  4 min read
• Press Releases

  Convergent Therapeutics Appoints Barbara Duncan to Board of Directors

  December 11, 2024

   · 

  3 min read
• Press Releases

  TikkunLev Therapeutics Announces the Publication of a Seminal Study in Nature Regenerative Medicine, Demonstrating the Potential Best-in-Class Profile of its cBIN1 Precision Therapy for Heart Failure

  December 11, 2024

   · 

  4 min read
• Press Releases

  Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology

  December 11, 2024

   · 

  8 min read
• Press Releases

  NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement

  December 11, 2024

   · 

  5 min read
• Press Releases

  NorthStar Medical Radioisotopes and Ariceum Therapeutics Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)

  December 11, 2024

   · 

  5 min read
• Press Releases

  Meitheal Pharmaceuticals Grows Specialty Biopharmaceuticals Portfolio with Exclusive Commercial Licensing Agreement for XENLETA® (lefamulin acetate)

  December 11, 2024

   · 

  10 min read